Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Oppenheimer

S&P 500 Hits New High on Apple Earnings: Stock Market Today

Apple rounded out a big week of mega-cap earnings on a high note, sending two of the three main equity indexes to new highs on Friday.

Kiplinger

Amazon Just Signed a Major Deal to Supply Its In-House Chips to Meta Platforms. AMZN Stock Now Has Multiple AI Chip Catalysts.

With demand surging, Amazon is moving beyond cloud into AI chips, and its growing silicon push is opening multiple new growth catalysts.

Barchart

Michael moonwalks to $217m opening weekend, shattering box office records for a biopic

Michael Jackson biopic has shrugged off controversy, bad reviews and a troubled production to take $217m worldwide, including $97m in North America

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Marvell Stock Just Got a New Street-High Price Target. Should You Buy Shares Here?

Oppenheimer has grown more bullish on Marvell as AI demand and growth projections strengthen. Does this justify buying at current levels?

Barchart

Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Revolution Medicines stock rallies on impressive daraxonrasib Phase 3 results. Here’s why RVMD shares may sustain the momentum moving forward.

Barchart

Why Oppenheimer Is Betting on Monolithic Power Stock Alongside Nvidia and Marvell Here

Oppenheimer sees Monolithic Power benefiting from AI demand, with long-cycle opportunities to translate into sustained upside.

Barchart

Netflix Just Admitted It Needs More Money. Is That a Red Flag for NFLX Stock?

In order to pay for its content budget, Netflix will be hiking subscription prices. Is that a red flag for investors or just part of a normal growth plan?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Project Hail Mary flies past huge sci-fi franchise to become highest grossing film of the year in the US

Sci-fi movie has earned $164.3 million in two weeks, surpassing ‘Avatar: Fire and Ash,’ which has made $153.7 million so far this year

The Independent UK

Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip?

Wave Life Sciences stock sinks as Phase 1 data for obesity drug disappoints investors. But Oppenheimer still recommends loading up on WVE shares today.

Barchart

Oppenheimer Is Bullish on Target Hospitality Stock Amid Major Data Center Pivot: Analysts Call for 16% Upside

Target Hospitality is gaining fresh Wall Street support as its shift toward housing workers tied to AI data center and power infrastructure starts to reshape its growth story.

Barchart

Project Hail Mary Blasted Off On Opening Night (And Christopher Nolan Better Watch Out)

Project Hail Mary is off to an explosive start at the box office.

Cinemablend

Stocks Extend Weekly Losing Streak: Stock Market Today

Efforts to boost crude supplies did little to stem worries of rising oil prices and inflation ahead of next week's Fed meeting.

Kiplinger

'Some of the best 4K Blu-rays I've ever tested' — Gruv is having a 3 for $39 4K Blu-ray sale, and I've picked the 6 best discs, all of which I've personally tested

Gruv's 3 for $39 4K Blu-ray sale is incredible value and it features some of the best 4K discs I've tested!

TechRadar

I tested three compact Dolby Atmos soundbars from Sonos, Sony and Denon — this is the one I'd buy with my own money

Three compact Dolby Atmos soundbars, the same five movie scenes — which ones come out on top?

TechRadar

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Dear Vertiv Stock Fans, Mark Your Calendars for March 23

Vertiv shares rally ahead of inclusion in the S&P 500 index on Mar. 23. Oppenheimer explains why VRT stock remains worth owning in 2026.

Barchart

Why Oppenheimer Says Oracle Stock Can Gain 25% from Here

Oppenheimer has initiated coverage of ORCL stock with a $185 price target.

Barchart

Are the Best Days Over for IBM Stock? What Price Volatility Tells Us and How You Can Trade IBM Now.

IBM’s volume was three times its 30-day average yesterday. It also had a high standard deviation of -3.46. Big moves are the norm for IBM; this latest decline suggests the good times could be over.

Barchart

Why 1 Analyst Is Betting on 30% Upside for This Beaten-Down Software Stock

Oppenheimer’s analyst sees notable upside in Unity as the company’s strengthening fundamentals outweigh AI disruption fears.

Get all your
news in one place.

100's of premium titles.
One news app.

Total Film

"The loss of a studio is a huge blow": Christopher Nolan says he has "very, very significant concerns" about the Warner Bros. Netflix sale

Christopher Nolan speaks out about Netflix buying Warner Bros. as the new president of the DGA

Cinemablend

Christopher Nolan Gets Real About Netflix's Warner Bros. Acquisition Being A ‘Huge Blow’

This is a major shakeup in Hollywood.

Barchart

This Old-School Company Is Up 100% on AI Demand. Should You Buy Shares Now?

With shares of this old-school glass pioneer soaring triple digits over the past year, can the AI-driven momentum push the stock even higher?

Cinemablend

That Time Emily Blunt Gave David Krumholtz Some Solid Hollywood Advice (That Supergirl Promptly Ignored)

Sometimes you have to “trust the process."

Barchart

H200 Component Production Is Halted. What That Means for Nvidia, and Should You Buy the NVDA Stock Dip Here?

Nvidia stock sinks on reports the company’s suppliers have halted production of H200 components. But Oppenheimer continues to recommend buying NVDA shares in 2026.

Cinemablend

Christopher Nolan Is Delivering A Special Sneak Peek At The Odyssey, And You'll Be Able To See It Very Soon

Brace yourselves for an epic.

Benzinga

Broadcom To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations